While both are called medullary carcinoma, these cancers differ in many ways: ...

Specifically, the new indication covers advanced or metastatic medullary thyroid cancer (MTC) with a RET mutation, advanced or metastatic thyroid cancer with a RET gene fusion that can’t be ...

It then filed for approval in the two thyroid cancer indications – RET mutant medullary thyroid cancer and RET fusion-positive thyroid cancer at the beginning of this month. Massachusetts ...

If you have thyroid cancer, you may be facing surgery. It’s the most common treatment, and it’s usually very successful. Your surgery will depend on the kind of thyroid cancer you have.

After rising over a 35-year period, thyroid cancer incidence in the U.S. plateaued from 2010 to 2019, according to findings ...

RET-mutant medullary thyroid cancer that has spread to other parts of the body (advanced) RET fusion-positive advanced thyroid cancer, when radioactive active iodine has not worked if it is an ...

The incidence of thyroid cancer in the United States, having plateaued in 2009 after a decades-long increase, has remained stable since then, despite efforts to control an ongoing overdiagnosis of ...

Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window The annual incidence of thyroid cancer rose significantly from 5.0 cases per 100,000 people in 1975 to 14.6 cases per ...

A resource impact template has not been produced for this appraisal. The resource impact template for selpercatinib for advanced thyroid cancer with RET alterations untreated with a targeted cancer ...